Short Interest in Nephros, Inc. (NASDAQ:NEPH) Increases By 1,750.0%

Nephros, Inc. (NASDAQ:NEPH) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 11,100 shares, a growth of 1,750.0% from the October 15th total of 600 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily volume of 11,600 shares, the short-interest ratio is presently 1.0 days.

Hedge Funds Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP purchased a new position in shares of Nephros, Inc. (NASDAQ:NEPH) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned about 0.17% of Nephros at the end of the most recent reporting period. 41.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Benchmark reiterated a “speculative buy” rating and issued a $5.00 target price on shares of Nephros in a research report on Tuesday.

Nephros Price Performance

Shares of Nephros stock traded down $0.01 during mid-day trading on Wednesday, reaching $1.63. 4,268 shares of the stock traded hands, compared to its average volume of 15,089. The business has a 50-day moving average of $1.62 and a 200 day moving average of $1.93. Nephros has a fifty-two week low of $1.36 and a fifty-two week high of $4.04.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.